Johnson joins Inside Texas Politics to discuss the race and what distinguishes her from Colin Allred in U.S. House District 33 runoff ...

US-based biotechnology company Rallybio has entered a definitive agreement to acquire Candid Therapeutics through a merger transaction. Following completion, the combined entity will operate as Candid ...

T-cell engager (TCE) specialist Candid Therapeutics has entered into a reverse merger agreement with Rallybio that will allow ...

You won't find them on financial statements, and they're not easily traded. But invisible assets can hold significant value, ...

Twelve months ago, drugmakers came roaring into 2025, fueled by a massive year of growth that peaked in the fourth quarter of ...

Filling her van with packages, the woman in the t-shirt and loose pants looks just like any other hard-working member of the ...

Through history, the figure of the female heir has triggered mixed emotions, from uneasiness to envy and even lust. Heiress have come in all shapes and sizes, from the spoiled scions to the princesses ...

Neurocrine Biosciences has rebounded 60% since April 2025, driven by robust Ingrezza sales and Crenessity's uncontested launch. Read why NBIX stock is a hold.

Up 17% through February 2026, Johnson & Johnson stock (NYSE: JNJ) is riding a wave of momentum fueled by a "triple threat" of high-growth oncology sales, a massive MedTech rebound, and a surprise ...

Johnson & Johnson (JNJ) on Wednesday announced plans to construct a cell therapy manufacturing facility in Pennsylvania at an investment of more than $1B, further boosting its business operations in ...

The guard tandem of Johnson & Johnson led third-ranked South Carolina over No. 6 LSU on Feb. 14 and kept driving USC toward the SEC regular-season championship ...

CMO, discussed a presentation from Maui Derm 2026 in which he spoke about therapies in the pipeline for psoriasis.